Role for mammalian chitinase 3-like protein 1 in traumatic brain injury

Neuropathology

Volumn 35, Issue 2, 2015, Pages 95-106

  Wiley, Clayton A ^a   Bonneh Barkay, Dafna ^a   Dixon, C Edward ^a   Lesniak, Andrew ^a   Wang, Guoji ^a   Bissel, Stephanie J ^a   Kochanek, Patrick M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

BRP 39; Chitinase 3 like protein 1; Controlled cortical impact; Neuroinflammation; Traumatic brain injury

Indexed keywords

BREAST REGRESSION PROTEIN 39; CHITINASE 3 LIKE PROTEIN 1; GLYCOPROTEIN; UNCLASSIFIED DRUG; CHITINASE 3-LIKE 1, MOUSE; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; NERVE PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; FEMALE; HEMISPHERE; HISTOPATHOLOGY; MACROPHAGE; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPATIAL MEMORY; TRAUMATIC BRAIN INJURY; WILD TYPE; ANIMAL; BRAIN; BRAIN INJURY; C57BL MOUSE; ENCEPHALITIS; GENETICS; GLIOSIS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; BRAIN INJURIES; ENCEPHALITIS; FEMALE; GLIOSIS; GLYCOPROTEINS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NERVE TISSUE PROTEINS;

EID: 84926474526     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12158     Document Type: Article

References (38)

1. Laker SR. Epidemiology of concussion and mild traumatic brain injury. PM R 2011; 3: S354-S358.
2. Carlson KF, Kehle SM, Meis LA etal. Prevalence, assessment, and treatment of mild traumatic brain injury and posttraumatic stress disorder: a systematic review of the evidence. J Head Trauma Rehabil 2011; 26: 103-115.
3. Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune response by head injury. Injury 2007; 38: 1392-1400.
4. Nakagawa A, Manley GT, Gean AD etal. Mechanisms of primary blast-induced traumatic brain injury: insights from shock-wave research. J Neurotrauma 2011; 28: 1101-1119.
5. Rhodes J. Peripheral immune cells in the pathology of traumatic brain injury? Curr Opin Crit Care 2011; 17: 122-130.
6. Laird MD, Vender JR, Dhandapani KM. Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 2008; 16: 154-164.
7. Voskuhl RR, Peterson RS, Song B etal. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 2009; 29: 11511-11522.
8. Haroon F, Drogemuller K, Handel U etal. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation. J Immunol 2011; 186: 6521-6531.
9. Heppner FL, Greter M, Marino D etal. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 2005; 11: 146-152.
10. Brambilla R, Dvoriantchikova G, Barakat D, Ivanov D, Bethea JR, Shestopalov VI. Transgenic inhibition of astroglial NF-kappaB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis. J Neuroinflammation 2012; 9: 213.
11. Brambilla R, Persaud T, Hu X etal. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J Immunol 2009; 182: 2628-2640.
12. Bush TG, Puvanachandra N, Horner CH etal. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999; 23: 297-308.
13. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004; 24: 2143-2155.
14. Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006; 129: 2761-2772.
15. Bonneh-Barkay D, Zagadailov P, Zou H etal. YKL-40 expression in traumatic brain injury: an initial analysis. J Neurotrauma 2010; 27: 1215-1223.
16. Bonneh-Barkay D, Wang G, Starkey A, Hamilton RL, Wiley CA. In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation 2010; 7: 34.
17. Lee CG, Hartl D, Lee GR etal. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med 2009; 206: 1149-1166.
18. Sinz EH, Kochanek PM, Dixon CE etal. Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J Clin Invest 1999; 104: 647-656.
19. Kochanek PM, Vagni VA, Janesko KL etal. Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab 2006; 26: 565-575.
20. de Olmos JS, Beltramino CA, de Lorenzo S. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol Teratol 1994; 16: 545-561.
21. Bonneh-Barkay D, Wang G, Laframboise WA, Wiley CA, Bissel SJ. Exacerbation of experimental autoimmune encephalomyelitis in the absence of breast regression protein 39/chitinase 3-like 1. J Neuropathol Exp Neurol 2012; 71: 948-958.
22. Hoffman GE, Le WW. Just cool it! Cryoprotectant anti-freeze in immunocytochemistry and in situ hybridization. Peptides 2004; 25: 425-431.
23. Isse K, Lesniak A, Grama K, Roysam B, Minervini MI, Demetris AJ. Digital transplantation pathology: combining whole slide imaging, multiplex staining and automated image analysis. Am J Transplant 2012; 12: 27-37.
24. Tehranian R, Rose ME, Vagni V etal. Transgenic mice that overexpress the anti-apoptotic Bcl-2 protein have improved histological outcome but unchanged behavioral outcome after traumatic brain injury. Brain Res 2006; 1101: 126-135.
25. Dixon CE, Clifton GL, Lighthall JW, Yaghmai AA, Hayes RL. A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods 1991; 39: 253-262.
26. Hall ED, Bryant YD, Cho W, Sullivan PG. Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods. J Neurotrauma 2008; 25: 235-247.
27. Switzer RC, 3rd. Application of silver degeneration stains for neurotoxicity testing. Toxicol Pathol 2000; 28: 70-83.
28. Bonneh-Barkay D, Bissel SJ, Wang G etal. YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am J Pathol 2008; 173: 130-143.
29. Foley LM, Hitchens TK, Ho C etal. Magnetic resonance imaging assessment of macrophage accumulation in mouse brain after experimental traumatic brain injury. J Neurotrauma 2009; 26: 1509-1519.
30. Bussink AP, Speijer D, Aerts JM, Boot RG. Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics 2007; 177: 959-970.
31. Lee CG, Da Silva CA, Dela Cruz CS etal. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 2011; 73: 479-501.
32. Ober C, Chupp GL. The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases. Curr Opin Allergy Clin Immunol 2009; 9: 401-408.
33. Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006; 53: 172-209.
34. Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 1997; 237: 46-54.
35. Rehli M, Niller HH, Ammon C etal. Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J Biol Chem 2003; 278: 44058-44067.
36. Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C. The CCN family: a new class of inflammation modulators? Biochimie 2011; 93: 377-388.
37. Goldstein LE, Fisher AM, Tagge CA etal. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med 2012; 4: 134ra60.
38. Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 2013; 136: 28-42.